Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Pregnancy Hypertens ; 36: 101116, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38408407

ABSTRACT

BACKGROUND: The early and accurate diagnosis of preeclampsia is crucial to avoid serious complications for both the mother and baby. However, the current diagnostic methods are limited, and there is a need for new diagnostic biomarkers. Previous studies have shown that cathepsin D (CTD) participates in the pathophysiology of preeclampsia and is present in urine samples, making it a potential biomarker for the disease. This study aimed to compare urinary and serum levels of CTD in preeclamptic and normotensive women and analyze its potential role as a diagnostic biomarker in preeclampsia. METHODS: The study included thirty-nine patients with preeclampsia and twelve normotensive pregnant women as controls. Biomarkers were determined using Multiplex Assay kit, and serum prolactin (Prl) and urinary TNF-α levels were also evaluated. Statistical analysis was conducted using the Mann-Whitney U test. RESULTS: We found that urinary and serum CTD levels were significantly higher in the preeclampsia group than in the normotensive group, suggesting that CTD could be a diagnostic biomarker for preeclampsia. No significant differences were found in the levels of serum prolactin or urinary TNF-α between the two groups. CONCLUSIONS: The study provides evidence that non-invasive biological samples such as urine can be used to improve new therapeutic strategies for the early management of preeclampsia.


Subject(s)
Biomarkers , Cathepsin D , Pre-Eclampsia , Prolactin , Humans , Female , Pre-Eclampsia/urine , Pre-Eclampsia/blood , Pre-Eclampsia/diagnosis , Pregnancy , Cathepsin D/urine , Cathepsin D/blood , Biomarkers/urine , Biomarkers/blood , Adult , Case-Control Studies , Prolactin/blood , Prolactin/urine , Tumor Necrosis Factor-alpha/blood , Tumor Necrosis Factor-alpha/urine , Young Adult
2.
Zebrafish ; 13(5): 442-8, 2016 10.
Article in English | MEDLINE | ID: mdl-27557408

ABSTRACT

Monceren 250 SC is a commercial fungicide with the active ingredient 1-(4-chlorobenzyl)-1-(cyclopentyl)-3-phenylurea, also known as pencycuron. This compound inhibits the growth of fungi as Rhizoctonia solani that invades potato, rice, and cotton or as Pellicularia spp, which contaminates lettuce and tomato crops. In this study, we assessed genotoxicity or DNA damage by the alkaline comet assay in zebrafish blastula-stage embryos exposed to 250 to 1250 µg/mL of the Monceren fungicide or to Bleomycin (0.25 µg/mL) used as a positive control. Additionally, survival and spontaneous movement were monitored in embryos after exposure to different concentrations of fungicide. DNA damage was evaluated using three genotoxicity parameters of the alkaline comet assay: tail length, tail moment, and tail intensity. We found that Monceren 250 SC fungicide induces DNA damage, as shown by significant increases in the three genotoxicity parameters in zebrafish embryos compared with control embryos nonexposed to Monceren. Tail intensity was the more accurate parameter to evaluate genotoxicity levels in zebrafish embryos. At 48 h after exposure to the fungicide, the survival rate of larvae-embryos was reduced to 40-45%. This study shows that the Monceren 250 SC fungicide exerts genotoxic effects in zebrafish during early stages of development.


Subject(s)
DNA Damage , Fungicides, Industrial/toxicity , Water Pollutants, Chemical/toxicity , Zebrafish/genetics , Animals , Comet Assay , Embryo, Nonmammalian/drug effects , Zebrafish/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...